Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147132 · ClinicalTrials.gov registry record · Phase 4
Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients
A Phase 4 study, sponsored by University of Cincinnati.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT02147132: Clinical Trial Phase 4 study, sponsored by University of Cincinnati.
NCT02147132 is a Phase 4 study that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 7 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02147132, a Phase 4 study, was terminated before completion, sponsored by University of Cincinnati.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
The objective is to provide a preliminary test of the ability of two pharmacological treatments, the nicotine nasal spray and varenicline, relative to placebos, to reduce smoking during the 4 hours following methadone dosing.
Primary Outcome
Subjects will be given a special electronic cigarette lighter called Quitbit.The electronic lighter will record a timestamp for each time the lighter is used to light a cigarette. Data will be collected from the lighter at each study visit. This will measure how many cigarettes are smoked and when.
Interventions
- DRUG Varenicline
- DRUG Placebo Nasal Spray
- DRUG Nicotine Nasal Spray
- DRUG Placebo Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-08-25 |
| Phase | Phase 4 |
Why NCT02147132 stopped before completion
NCT02147132 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Varenicline is the first listed.
NCT02147132 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02147132 about?
NCT02147132 is a clinical study titled "Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients". The objective is to provide a preliminary test of the ability of two pharmacological treatments, the nicotine nasal spray and varenicline, relative to placebos, to reduce smoking during the 4 hours following methadone dosing.
What is the current status of trial NCT02147132?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2016-03. Estimated completion is 2017-08-25.
What interventions are being tested in trial NCT02147132?
The interventions under investigation include: Varenicline (DRUG), Placebo Nasal Spray (DRUG), Nicotine Nasal Spray (DRUG), Placebo Varenicline (DRUG).
Who is sponsoring clinical trial NCT02147132?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02147132's enrollment target sits among peer trials
7 1981st of 2000 higher than 18 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia